The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...
Kimberly-Clark, the maker of Huggies, is set to acquire Kenvue, the parent company of Tylenol, in a nearly $50 billion deal.
The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...
Just The News on MSN
Kimberly-Clark to buy Tylenol maker Kenvue for nearly $50 billion
The announcement comes weeks after President Trump made claims linking Tylenol to autism in pregnant women's unborn babies, ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...
The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.
Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...
The lawsuit accuses pharmaceutical companies of “deceptively marketing” Tylenol as a safe option for pregnant mothers.
Donald Trump and his Secretary of Health and Human Services, RFK Jr., previously claimed an unfounded link between autism and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback